Heru Completes FDA Registration Following a $2.7M Seed Round: Expands Leadership Team
The funding facilitates the completion of current clinical trials for FDA clearance of Heru’s wearable AI platform and subsequent commercialization efforts.
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
The funding facilitates the completion of current clinical trials for FDA clearance of Heru’s wearable AI platform and subsequent commercialization efforts.
The proceeds of the financing will be used to expand Peptilogics’ computational platform and invest in technologies to improve its drug design engine, as well as accelerate the development of a pipeline of peptide therapeutics
December 18, 2020 Ingenion Medical today, announces it has been awarded nearly £100,000 in grant funding from Innovate UK, the country’s innovation agency. Ingenion Medical will